AGIO Financials
Agios Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$35.14
Market Cap
$2.05B
EPS
$-7.12
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$36.50M
Gross Profit
-
Operating Income
-
Net Income
$673.73M
EPS (Diluted)
$11.64
Balance Sheet Highlights
Total Assets
$1.66B
Total Liabilities
$122.24M
Shareholders Equity
-
Cash & Equivalents
$76.25M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-389.84M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-540.2%
Operating Margin
-6.1%
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AGIO revenue?
AGIO's most recent quarterly revenue was $36.50M. Annual revenue can be calculated by summing the four most recent quarters.
Is AGIO profitable?
AGIO reported a profit of $673.73M in the most recent quarter.
What is AGIO market cap?
AGIO has a market capitalization of $2.05B, making it a mid-cap stock.
Does AGIO have debt?
View AGIO's balance sheet for debt information.
What is AGIO cash flow?
Cash flow data is available in the full financial statements.